STOCK TITAN

Viatris to Report First Quarter 2024 Financial Results on May 9, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Viatris Inc. (VTRS) is set to announce its first quarter 2024 financial results on May 9, 2024, before the U.S. financial markets open.
Positive
  • None.
Negative
  • None.

PITTSBURGH, April 16, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report its first quarter 2024 financial results on Thursday, May 9, 2024, before the open of the U.S. financial markets. Chief Executive Officer Scott A. Smith and other Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.

Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.

About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India.  Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X (formerly Twitter).

Viatris OUS Logo (PRNewsfoto/Viatris Inc.)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-report-first-quarter-2024-financial-results-on-may-9-2024-302118621.html

SOURCE Viatris Inc.

Viatris will report its first quarter 2024 financial results on May 9, 2024.

The ticker symbol for Viatris is VTRS.

Viatris will announce its first quarter 2024 financial results before the open of the U.S. financial markets.
Viatris Inc.

NASDAQ:VTRS

VTRS Rankings

VTRS Latest News

VTRS Stock Data

13.99B
1.18B
0.35%
83.36%
3.06%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
CANONSBURG

About VTRS

mylan is a global pharmaceutical company committed to setting new standards in healthcare. working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. we offer a growing portfolio of around 1,400 generic pharmaceuticals and several brand medications. in addition, we offer a wide range of antiretroviral therapies, upon which nearly 50% of hiv/aids patients in developing countries depend. we also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in about 145 countries and territories. our workforce of approximately 30,000 people is dedicated to creating better health for a better world, one person at a time. learn more at mylan.com.